{
    "Trade/Device Name(s)": [
        "Myglucohealth Models MGH-1",
        "Myglucohealth Models MGH-BT1",
        "Myglucohealth Glucose Monitoring System",
        "Myglucohealth Glucose Monitoring Systems"
    ],
    "Submitter Information": "Entra Health Systems, Ltd.",
    "510(k) Number": "K081703",
    "Predicate Device Reference 510(k) Number(s)": [
        "K072369"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "December 23, 2008",
    "Summary Letter Received Date": "December 29, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Monitoring System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MGH-BT1 blood glucose meter",
        "MGH-1 blood glucose meter"
    ],
    "Method(s)/Technology(ies)": [
        "Biosensor"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Instrument",
        "System",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Myglucohealth Models MGH-1 and MGH-BT1 blood glucose monitoring system with biosensor and Bluetooth wireless data transmission",
    "Indications for Use Summary": "Quantitative measurement of glucose in capillary whole blood from various body sites by diabetic patients or health care professionals; not for diagnosis or neonatal use",
    "fda_folder": "Clinical Chemistry"
}